TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

H.P. ACTHAR GEL

REPOSITORY CORTICOTROPIN
Immunology Approved 2010-10-15
1
Indication
--
Phase 3 Trials
15
Years on Market

Details

Status
Prescription
First Approved
2010-10-15
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: REPOSITORY CORTICOTROPIN

H.P. ACTHAR GEL Approval History

Loading approval history...

What H.P. ACTHAR GEL Treats

8 indications

H.P. ACTHAR GEL is approved for 8 conditions since its original approval in 2010. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Infantile Spasms
  • Multiple Sclerosis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Dermatomyositis
  • Erythema Multiforme
Source: FDA Label

Drugs Similar to H.P. ACTHAR GEL

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ABRILADA
ADALIMUMAB-AFZB
3 shared
Pfizer
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
AMJEVITA
ADALIMUMAB-ATTO
3 shared
Amgen
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
CIMZIA
CERTOLIZUMAB PEGOL
3 shared
UCB INC
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
CORTEF
HYDROCORTISONE
3 shared
PHARMACIA AND UPJOHN
Shared indications:
Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis
CYLTEZO
ADALIMUMAB-ADBM
3 shared
Boehringer Ingelheim
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
ENBREL
ETANERCEPT
3 shared
IMMUNEX
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
HADLIMA
ADALIMUMAB-BWWD
3 shared
SAMSUNG BIOEPIS CO LTD
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
HULIO
ADALIMUMAB-FKJP
3 shared
Viatris
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
HUMIRA
ADALIMUMAB
3 shared
AbbVie
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
HYRIMOZ
ADALIMUMAB-ADAZ
3 shared
Novartis
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
IDACIO
ADALIMUMAB-AACF
3 shared
Fresenius Kabi
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
PREDNISONE INTENSOL
PREDNISONE
3 shared
Hikma
Shared indications:
Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis
REMICADE
INFLIXIMAB
3 shared
Johnson & Johnson
Shared indications:
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
SIMLANDI
ADALIMUMAB-RYVK
3 shared
ALVOTECH USA INC
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
SIMPONI
GOLIMUMAB
3 shared
Johnson & Johnson
Shared indications:
Rheumatoid arthritisPsoriatic arthritisAnkylosing spondylitis
SIMPONI ARIA
GOLIMUMAB
3 shared
Johnson & Johnson
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
XELJANZ XR
TOFACITINIB CITRATE
3 shared
Pfizer
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
YUFLYMA
ADALIMUMAB-AATY
3 shared
CELLTRION
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
YUSIMRY
ADALIMUMAB-AQVH
3 shared
COHERUS BIOSCIENCES INC
Shared indications:
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
BIMZELX
BIMEKIZUMAB-BKZX
2 shared
UCB INC
Shared indications:
Psoriatic ArthritisAnkylosing Spondylitis
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

H.P. ACTHAR GEL FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. Acthar Gel is indicated for the treatment of exacerbations of multiple sclerosis in adults. Acthar Gel may be used for the following disorders and diseases: rheumatic ; collagen ; dermatologic ; allergic states ; ophthalmic ; respiratory ; and edematous state. 1.1 Infantile Spasms Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. 1.2 Multiple Sclerosis Acthar Gel is indicated for the treatment of acut...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.